2024 Q2 Form 10-Q Financial Statement
#000162828024020450 Filed on May 06, 2024
Income Statement
| Concept | 2024 Q2 | 2024 Q1 | 2023 Q1 |
|---|---|---|---|
| Revenue | $17.41M | $18.05M | $18.99M |
| YoY Change | -9.71% | -4.94% | -59.16% |
| Cost Of Revenue | $1.217M | $2.510M | $590.0K |
| YoY Change | 105.23% | 325.42% | 11.53% |
| Gross Profit | $16.19M | $15.54M | $18.40M |
| YoY Change | -13.36% | -15.54% | -59.97% |
| Gross Profit Margin | 93.01% | 86.1% | 96.89% |
| Selling, General & Admin | $20.94M | $23.42M | $30.43M |
| YoY Change | -18.68% | -23.04% | -18.45% |
| % of Gross Profit | 129.31% | 150.69% | 165.37% |
| Research & Development | $24.30M | $25.74M | $38.55M |
| YoY Change | -23.0% | -33.25% | -21.43% |
| % of Gross Profit | 150.03% | 165.57% | 209.5% |
| Depreciation & Amortization | $326.0K | $331.0K | $694.0K |
| YoY Change | -57.61% | -52.31% | 16.84% |
| % of Gross Profit | 2.01% | 2.13% | 3.77% |
| Operating Expenses | $45.23M | $49.16M | $69.38M |
| YoY Change | -21.68% | -29.15% | -19.97% |
| Operating Profit | -$29.04M | -$33.61M | -$50.98M |
| YoY Change | -25.66% | -34.06% | 25.17% |
| Interest Expense | $12.68M | $12.50M | -$8.912M |
| YoY Change | -189.2% | -240.22% | -139.56% |
| % of Operating Profit | |||
| Other Income/Expense, Net | -$6.672M | -$12.14M | $140.0K |
| YoY Change | -2218.1% | -8773.57% | 1650.0% |
| Pretax Income | -$35.70M | -$45.80M | -$59.69M |
| YoY Change | -33.55% | -23.27% | 234.74% |
| Income Tax | $200.0K | $200.0K | -$262.0K |
| % Of Pretax Income | |||
| Net Earnings | -$36.54M | -$46.61M | -$59.43M |
| YoY Change | -22.44% | -21.57% | 256.68% |
| Net Earnings / Revenue | -209.9% | -258.16% | -312.9% |
| Basic Earnings Per Share | -$0.38 | -$0.56 | -$0.73 |
| Diluted Earnings Per Share | -$0.38 | -$0.56 | -$0.74 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 82.81M shares | 82.53M shares | 80.81M shares |
| Diluted Shares Outstanding | 95.69M shares | 82.55M shares | 80.81M shares |
Balance Sheet
| Concept | 2024 Q2 | 2024 Q1 | 2023 Q1 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $300.1M | $234.3M | $310.5M |
| YoY Change | -13.64% | -24.56% | -27.93% |
| Cash & Equivalents | $300.1M | $234.3M | $310.5M |
| Short-Term Investments | |||
| Other Short-Term Assets | $17.18M | $16.74M | $27.17M |
| YoY Change | -21.92% | -38.4% | 48.93% |
| Inventory | $15.19M | $16.00M | $18.25M |
| Prepaid Expenses | |||
| Receivables | $22.87M | $23.19M | $24.04M |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $355.4M | $290.2M | $380.0M |
| YoY Change | -13.92% | -23.63% | -22.08% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $5.483M | $5.785M | $15.71M |
| YoY Change | -66.51% | -63.17% | 47.3% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | $260.0K | $930.0K | $29.53M |
| YoY Change | -99.08% | -96.85% | -23.75% |
| Other Assets | $992.0K | $986.0K | $28.84M |
| YoY Change | -97.26% | -96.58% | -6.75% |
| Total Long-Term Assets | $16.42M | $17.76M | $87.67M |
| YoY Change | -82.62% | -79.74% | -6.91% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $355.4M | $290.2M | $380.0M |
| Total Long-Term Assets | $16.42M | $17.76M | $87.67M |
| Total Assets | $371.8M | $308.0M | $467.7M |
| YoY Change | -26.71% | -34.15% | -19.63% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $10.71M | $14.32M | $8.694M |
| YoY Change | -8.41% | 64.65% | -47.16% |
| Accrued Expenses | $46.92M | $48.67M | |
| YoY Change | |||
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $14.98M | ||
| YoY Change | 98.94% | ||
| Total Short-Term Liabilities | $57.63M | $62.99M | $81.09M |
| YoY Change | -28.48% | -22.32% | 14.57% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $429.9M | $423.2M | $324.5M |
| YoY Change | 5.52% | 30.42% | 8.49% |
| Other Long-Term Liabilities | $6.624M | $6.524M | $24.38M |
| YoY Change | -76.27% | -73.24% | -50.55% |
| Total Long-Term Liabilities | $6.624M | $6.524M | $348.9M |
| YoY Change | -98.48% | -98.13% | 0.13% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $57.63M | $62.99M | $81.09M |
| Total Long-Term Liabilities | $6.624M | $6.524M | $348.9M |
| Total Liabilities | $503.4M | $502.4M | $430.0M |
| YoY Change | -2.41% | 16.84% | 2.57% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$1.419B | -$1.382B | |
| YoY Change | |||
| Common Stock | $8.233M | $7.312M | |
| YoY Change | |||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | $239.0K | $502.0K | |
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | -$131.7M | -$194.4M | $37.69M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $371.8M | $308.0M | $467.7M |
| YoY Change | -26.71% | -34.15% | -19.63% |
Cashflow Statement
| Concept | 2024 Q2 | 2024 Q1 | 2023 Q1 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$36.54M | -$46.61M | -$59.43M |
| YoY Change | -22.44% | -21.57% | 256.68% |
| Depreciation, Depletion And Amortization | $326.0K | $331.0K | $694.0K |
| YoY Change | -57.61% | -52.31% | 16.84% |
| Cash From Operating Activities | -$32.85M | -$44.10M | -$14.77M |
| YoY Change | -10.81% | 198.52% | -56.4% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $30.00K | $531.0K | $1.016M |
| YoY Change | -97.52% | -47.74% | -190.88% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $0.00 | ||
| YoY Change | -100.0% | ||
| Cash From Investing Activities | -$30.00K | -$531.0K | -$1.016M |
| YoY Change | -97.04% | -47.74% | -29.83% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 98.70M | $356.0K | -196.0K |
| YoY Change | 32.06% | -281.63% | -24.03% |
| NET CHANGE | |||
| Cash From Operating Activities | -32.85M | -$44.10M | -14.77M |
| Cash From Investing Activities | -30.00K | -$531.0K | -1.016M |
| Cash From Financing Activities | 98.70M | $356.0K | -196.0K |
| Net Change In Cash | 65.82M | -$44.27M | -15.98M |
| YoY Change | 78.37% | 176.98% | -55.09% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$32.85M | -$44.10M | -$14.77M |
| Capital Expenditures | $30.00K | $531.0K | $1.016M |
| Free Cash Flow | -$32.88M | -$44.63M | -$15.79M |
| YoY Change | -13.57% | 182.68% | -51.82% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2023Q1 | us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
425000 | usd |
| CY2024Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
33000 | usd |
| CY2023Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
0 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
356000 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
425000 | usd |
| CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-44270000 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-15983000 | usd |
| CY2024Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-43000 | usd |
| CY2023Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
89000 | usd |
| CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
278598000 | usd |
| CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
234285000 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
310547000 | usd |
| CY2024Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
3900000 | usd |
| CY2023Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
3714000 | usd |
| CY2024Q1 | us-gaap |
Proceeds From Interest Received
ProceedsFromInterestReceived
|
4382000 | usd |
| CY2023Q1 | us-gaap |
Proceeds From Interest Received
ProceedsFromInterestReceived
|
2795000 | usd |
| CY2024Q1 | adc |
Noncash Payment For Royalty Financing Transaction
NoncashPaymentForRoyaltyFinancingTransaction
|
-1229000 | usd |
| CY2023Q1 | adc |
Noncash Payment For Royalty Financing Transaction
NoncashPaymentForRoyaltyFinancingTransaction
|
-4885000 | usd |
| CY2024Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
9000 | usd |
| CY2023Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
411000 | usd |
| CY2024Q1 | adc |
Number Of Subsidiaries
NumberOfSubsidiaries
|
3 | subsidiary |
| CY2024Q1 | us-gaap |
Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
|
205000 | usd |
| CY2023Q1 | us-gaap |
Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
|
39000 | usd |
| CY2024Q1 | us-gaap |
Revenues
Revenues
|
18053000 | usd |
| CY2023Q1 | us-gaap |
Revenues
Revenues
|
18992000 | usd |
| CY2024Q1 | adc |
Cost Of Revenue Net
CostOfRevenueNet
|
2510000 | usd |
| CY2023Q1 | adc |
Cost Of Revenue Net
CostOfRevenueNet
|
-27000 | usd |
| CY2024Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
25735000 | usd |
| CY2023Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
38375000 | usd |
| CY2024Q1 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
11390000 | usd |
| CY2023Q1 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
15351000 | usd |
| CY2024Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
12031000 | usd |
| CY2023Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
15503000 | usd |
| CY2024Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
51666000 | usd |
| CY2023Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
69202000 | usd |
| CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-33613000 | usd |
| CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-50210000 | usd |
| CY2024Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
2948000 | usd |
| CY2023Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
2175000 | usd |
| CY2024Q1 | us-gaap |
Interest Expense
InterestExpense
|
12496000 | usd |
| CY2023Q1 | us-gaap |
Interest Expense
InterestExpense
|
10291000 | usd |
| CY2024Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-2595000 | usd |
| CY2023Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
833000 | usd |
| CY2024Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-12143000 | usd |
| CY2023Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-7283000 | usd |
| CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-45756000 | usd |
| CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-57493000 | usd |
| CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
163000 | usd |
| CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
518000 | usd |
| CY2024Q1 | adc |
Income Loss From Continuing Operations Before Equity Method Investments
IncomeLossFromContinuingOperationsBeforeEquityMethodInvestments
|
-45919000 | usd |
| CY2023Q1 | adc |
Income Loss From Continuing Operations Before Equity Method Investments
IncomeLossFromContinuingOperationsBeforeEquityMethodInvestments
|
-58011000 | usd |
| CY2024Q1 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-687000 | usd |
| CY2023Q1 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-1363000 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-46606000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-59374000 | usd |
| CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.56 | |
| CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.56 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.73 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.73 | |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
82552322 | shares |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
82552322 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
80805770 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
80805770 | shares |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-46606000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-59374000 | usd |
| CY2024Q1 | us-gaap |
Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
|
0 | usd |
| CY2023Q1 | us-gaap |
Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
|
39000 | usd |
| CY2024Q1 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-78000 | usd |
| CY2023Q1 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
141000 | usd |
| CY2024Q1 | adc |
Other Comprehensive Income Loss Before Oci Equity Method Investment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeOCIEquityMethodInvestmentNetOfTaxPortionAttributableToParent
|
-78000 | usd |
| CY2023Q1 | adc |
Other Comprehensive Income Loss Before Oci Equity Method Investment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeOCIEquityMethodInvestmentNetOfTaxPortionAttributableToParent
|
102000 | usd |
| CY2024Q1 | us-gaap |
Oci Equity Method Investment After Tax Parent
OciEquityMethodInvestmentAfterTaxParent
|
-30000 | usd |
| CY2023Q1 | us-gaap |
Oci Equity Method Investment After Tax Parent
OciEquityMethodInvestmentAfterTaxParent
|
-256000 | usd |
| CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-108000 | usd |
| CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-154000 | usd |
| CY2024Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-46714000 | usd |
| CY2023Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-59528000 | usd |
| CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-148249000 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-46606000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-643000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
281000 | usd |
| CY2024Q1 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-78000 | usd |
| CY2024Q1 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-78000 | usd |
| CY2024Q1 | adc |
Other Comprehensive Income Loss Before Oci Equity Method Investment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeOCIEquityMethodInvestmentNetOfTaxPortionAttributableToParent
|
-78000 | usd |
| CY2024Q1 | us-gaap |
Oci Equity Method Investment After Tax Parent
OciEquityMethodInvestmentAfterTaxParent
|
-30000 | usd |
| CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-108000 | usd |
| CY2024Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-46714000 | usd |
| CY2024Q1 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
0 | usd |
| CY2024Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
33000 | usd |
| CY2024Q1 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
323000 | usd |
| CY2024Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
158000 | usd |
| CY2024Q1 | adc |
Stockholders Equity Excluding Oci Period Increase Decrease
StockholdersEquityExcludingOCIPeriodIncreaseDecrease
|
514000 | usd |
| CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-194449000 | usd |
| CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
79451000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-59374000 | usd |
| CY2023Q1 | us-gaap |
Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
|
39000 | usd |
| CY2023Q1 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
141000 | usd |
| CY2023Q1 | adc |
Other Comprehensive Income Loss Before Oci Equity Method Investment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeOCIEquityMethodInvestmentNetOfTaxPortionAttributableToParent
|
102000 | usd |
| CY2023Q1 | us-gaap |
Oci Equity Method Investment After Tax Parent
OciEquityMethodInvestmentAfterTaxParent
|
-256000 | usd |
| CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-154000 | usd |
| CY2023Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-59528000 | usd |
| CY2023Q1 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
0 | usd |
| CY2023Q1 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
425000 | usd |
| CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
8074000 | usd |
| CY2023Q1 | adc |
Stockholders Equity Excluding Oci Period Increase Decrease
StockholdersEquityExcludingOCIPeriodIncreaseDecrease
|
8499000 | usd |
| CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
28422000 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-46606000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-59374000 | usd |
| CY2024Q1 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
0 | usd |
| CY2023Q1 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
-69000 | usd |
| CY2024Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
158000 | usd |
| CY2023Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
8074000 | usd |
| CY2024Q1 | us-gaap |
Amortization Of Advance Royalty
AmortizationOfAdvanceRoyalty
|
6864000 | usd |
| CY2023Q1 | us-gaap |
Amortization Of Advance Royalty
AmortizationOfAdvanceRoyalty
|
861000 | usd |
| CY2024Q1 | us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
503000 | usd |
| CY2023Q1 | us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
830000 | usd |
| CY2024Q1 | adc |
Deferred Royalty Obligation Cumulative Catch Up Adjustment
DeferredRoyaltyObligationCumulativeCatchUpAdjustment
|
-263000 | usd |
| CY2023Q1 | adc |
Deferred Royalty Obligation Cumulative Catch Up Adjustment
DeferredRoyaltyObligationCumulativeCatchUpAdjustment
|
-129000 | usd |
| CY2024Q1 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
748000 | usd |
| CY2023Q1 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
53000 | usd |
| CY2024Q1 | us-gaap |
Depreciation
Depreciation
|
331000 | usd |
| CY2023Q1 | us-gaap |
Depreciation
Depreciation
|
263000 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
512000 | usd |
| CY2023Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
460000 | usd |
| CY2024Q1 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-687000 | usd |
| CY2023Q1 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-1363000 | usd |
| CY2024Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
3068000 | usd |
| CY2023Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-616000 | usd |
| CY2024Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
174000 | usd |
| CY2023Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
19000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-1995000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-48901000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
568000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
348000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
420000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
0 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-1247000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-3663000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-3543000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-12300000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-514000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-322000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
-5345000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
0 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-44095000 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-15392000 | usd |
| CY2024Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
531000 | usd |
| CY2023Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1016000 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-531000 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-1016000 | usd |
| CY2024Q1 | us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
323000 | usd |
| CY2023Q1 | us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
425000 | usd |
| CY2024Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
33000 | usd |
| CY2023Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
0 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
356000 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
425000 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-15983000 | usd |
| CY2024Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-43000 | usd |
| CY2023Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
89000 | usd |
| CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
278598000 | usd |
| CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
326441000 | usd |
| CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
234285000 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
310547000 | usd |
| CY2024Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
3900000 | usd |
| CY2023Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
3714000 | usd |
| CY2024Q1 | us-gaap |
Proceeds From Interest Received
ProceedsFromInterestReceived
|
4382000 | usd |
| CY2023Q1 | us-gaap |
Proceeds From Interest Received
ProceedsFromInterestReceived
|
2795000 | usd |
| CY2024Q1 | adc |
Noncash Payment For Royalty Financing Transaction
NoncashPaymentForRoyaltyFinancingTransaction
|
-1229000 | usd |
| CY2023Q1 | adc |
Noncash Payment For Royalty Financing Transaction
NoncashPaymentForRoyaltyFinancingTransaction
|
-4885000 | usd |
| CY2024Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
9000 | usd |
| CY2023Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
411000 | usd |
| CY2024Q1 | adc |
Number Of Subsidiaries
NumberOfSubsidiaries
|
3 | subsidiary |
| CY2024Q1 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
748000 | usd |
| CY2024Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Use of Estimates</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on </span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could differ materially from those estimates.</span></div> | |
| CY2024Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
234300000 | usd |
| CY2024Q1 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
3364000 | usd |
| CY2024Q1 | us-gaap |
Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
|
3364000 | usd |
| CY2023Q4 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
296000 | usd |
| CY2023Q4 | us-gaap |
Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
|
296000 | usd |
| CY2024Q1 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
15944000 | usd |
| CY2024Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Use of Estimates</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on </span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could differ materially from those estimates.</span></div> | |
| CY2024Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
234300000 | usd |
| CY2024Q1 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
3364000 | usd |
| CY2024Q1 | us-gaap |
Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
|
3364000 | usd |
| CY2023Q4 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
296000 | usd |
| CY2023Q4 | us-gaap |
Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
|
296000 | usd |
| CY2023Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
16095000 | usd |
| CY2024Q1 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
53000 | usd |
| CY2023Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
82000 | usd |
| CY2024Q1 | us-gaap |
Inventory Net
InventoryNet
|
15997000 | usd |
| CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
16177000 | usd |
| CY2024Q1 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
15944000 | usd |
| CY2023Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
16095000 | usd |
| CY2024Q1 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
53000 | usd |
| CY2023Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
82000 | usd |
| CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
16177000 | usd |
| CY2024Q1 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
748000 | usd |
| CY2023Q1 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
53000 | usd |
| CY2024Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
10365000 | usd |
| CY2023Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
9897000 | usd |
| CY2024Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
4580000 | usd |
| CY2023Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
4275000 | usd |
| CY2024Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
5785000 | usd |
| CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
5622000 | usd |
| CY2024Q1 | us-gaap |
Depreciation
Depreciation
|
331000 | usd |
| CY2023Q1 | us-gaap |
Depreciation
Depreciation
|
263000 | usd |
| CY2023Q1 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
53000 | usd |
| CY2024Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
10365000 | usd |
| CY2023Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
9897000 | usd |
| CY2024Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
4580000 | usd |
| CY2023Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
4275000 | usd |
| CY2024Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
5785000 | usd |
| CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
5622000 | usd |
| CY2024Q1 | us-gaap |
Depreciation
Depreciation
|
331000 | usd |
| CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
200000 | usd |
| CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-45800000 | usd |
| CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
500000 | usd |
| CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-57500000 | usd |
| CY2024Q1 | us-gaap |
Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
|
59000 | usd |
| CY2024Q1 | us-gaap |
Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
|
59000 | usd |
| CY2023Q1 | us-gaap |
Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
|
82000 | usd |
| CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
200000 | usd |
| CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-45800000 | usd |
| CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
500000 | usd |
| CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-57500000 | usd |
| CY2024Q1 | adc |
Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
|
20709000 | usd |
| CY2023Q4 | adc |
Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
|
24902000 | usd |
| CY2024Q1 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
6029000 | usd |
| CY2023Q4 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
12693000 | usd |
| CY2024Q1 | adc |
Accrued Gross To Net Sales Adjustment Current
AccruedGrossToNetSalesAdjustmentCurrent
|
8804000 | usd |
| CY2023Q4 | adc |
Accrued Gross To Net Sales Adjustment Current
AccruedGrossToNetSalesAdjustmentCurrent
|
1543000 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
1432000 | usd |
| CY2023Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
1467000 | usd |
| CY2024Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
11696000 | usd |
| CY2023Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
11496000 | usd |
| CY2024Q1 | adc |
Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
|
48670000 | usd |
| CY2023Q4 | adc |
Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
|
52101000 | usd |
| CY2022Q3 | us-gaap |
Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
|
733568 | shares |
| CY2024Q1 | us-gaap |
Secured Long Term Debt
SecuredLongTermDebt
|
113200000 | usd |
| CY2023Q4 | us-gaap |
Secured Long Term Debt
SecuredLongTermDebt
|
112700000 | usd |
| CY2024Q1 | adc |
Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
|
20709000 | usd |
| CY2023Q4 | adc |
Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
|
24902000 | usd |
| CY2024Q1 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
6029000 | usd |
| CY2023Q4 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
12693000 | usd |
| CY2024Q1 | adc |
Accrued Gross To Net Sales Adjustment Current
AccruedGrossToNetSalesAdjustmentCurrent
|
8804000 | usd |
| CY2023Q4 | adc |
Accrued Gross To Net Sales Adjustment Current
AccruedGrossToNetSalesAdjustmentCurrent
|
1543000 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
1432000 | usd |
| CY2023Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
1467000 | usd |
| CY2024Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
11696000 | usd |
| CY2023Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
11496000 | usd |
| CY2024Q1 | adc |
Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
|
48670000 | usd |
| CY2023Q4 | adc |
Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
|
52101000 | usd |
| CY2022Q3 | us-gaap |
Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
|
733568 | shares |
| CY2024Q1 | us-gaap |
Secured Long Term Debt
SecuredLongTermDebt
|
113200000 | usd |
| CY2023Q4 | us-gaap |
Secured Long Term Debt
SecuredLongTermDebt
|
112700000 | usd |
| CY2023Q1 | us-gaap |
Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
|
172000 | usd |
| CY2024Q1 | us-gaap |
Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
|
38000 | usd |
| CY2023Q1 | us-gaap |
Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
|
74000 | usd |
| CY2023Q1 | us-gaap |
Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
|
74000 | usd |
| CY2024Q1 | us-gaap |
Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
|
38000 | usd |
| CY2021Q3 | adc |
Royalty Purchase Agreement
RoyaltyPurchaseAgreement
|
325000000 | usd |
| CY2021Q3 | us-gaap |
Proceeds From Royalties Received
ProceedsFromRoyaltiesReceived
|
225000000 | usd |
| CY2023 | us-gaap |
Proceeds From Royalties Received
ProceedsFromRoyaltiesReceived
|
75000000 | usd |
| CY2022Q4 | adc |
Deferred Royalty Obligation
DeferredRoyaltyObligation
|
222277000 | usd |
| CY2023 | adc |
Increase Decrease To Royalty Obligation Additional Proceeds From Sale Of Future Royalties
IncreaseDecreaseToRoyaltyObligationAdditionalProceedsFromSaleOfFutureRoyalties
|
75000000 | usd |
| CY2023 | adc |
Increase Decrease To Royalty Obligation Transaction Costs
IncreaseDecreaseToRoyaltyObligationTransactionCosts
|
1898000 | usd |
| CY2023 | adc |
Increase Decrease To Royalty Obligation Interest Expense
IncreaseDecreaseToRoyaltyObligationInterestExpense
|
27915000 | usd |
| CY2023 | adc |
Increase Decrease To Royalty Obligation Cumulative Catch Up Adjustment Other Net
IncreaseDecreaseToRoyaltyObligationCumulativeCatchUpAdjustmentOtherNet
|
-4972000 | usd |
| CY2023Q4 | adc |
Deferred Royalty Obligation
DeferredRoyaltyObligation
|
309613000 | usd |
| CY2024Q1 | adc |
Increase Decrease To Royalty Obligation Royalty Payments
IncreaseDecreaseToRoyaltyObligationRoyaltyPayments
|
-1229000 | usd |
| CY2024Q1 | adc |
Increase Decrease To Royalty Obligation Interest Expense
IncreaseDecreaseToRoyaltyObligationInterestExpense
|
8093000 | usd |
| CY2024Q1 | adc |
Increase Decrease To Royalty Obligation Cumulative Catch Up Adjustment Other Net
IncreaseDecreaseToRoyaltyObligationCumulativeCatchUpAdjustmentOtherNet
|
-263000 | usd |
| CY2024Q1 | adc |
Deferred Royalty Obligation
DeferredRoyaltyObligation
|
316214000 | usd |
| CY2024Q1 | adc |
Capital And Interest Guarantee Defined Benefit Plan
CapitalAndInterestGuaranteeDefinedBenefitPlan
|
1 | |
| CY2024Q1 | us-gaap |
Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
|
164000 | usd |
| CY2023Q1 | us-gaap |
Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
|
172000 | usd |
| CY2021Q3 | adc |
Royalty Purchase Agreement
RoyaltyPurchaseAgreement
|
325000000 | usd |
| CY2021Q3 | us-gaap |
Proceeds From Royalties Received
ProceedsFromRoyaltiesReceived
|
225000000 | usd |
| CY2023 | us-gaap |
Proceeds From Royalties Received
ProceedsFromRoyaltiesReceived
|
75000000 | usd |
| CY2022Q4 | adc |
Deferred Royalty Obligation
DeferredRoyaltyObligation
|
222277000 | usd |
| CY2023 | adc |
Increase Decrease To Royalty Obligation Additional Proceeds From Sale Of Future Royalties
IncreaseDecreaseToRoyaltyObligationAdditionalProceedsFromSaleOfFutureRoyalties
|
75000000 | usd |
| CY2023 | adc |
Increase Decrease To Royalty Obligation Transaction Costs
IncreaseDecreaseToRoyaltyObligationTransactionCosts
|
1898000 | usd |
| CY2023 | adc |
Increase Decrease To Royalty Obligation Royalty Payments
IncreaseDecreaseToRoyaltyObligationRoyaltyPayments
|
-8709000 | usd |
| CY2023 | adc |
Increase Decrease To Royalty Obligation Interest Expense
IncreaseDecreaseToRoyaltyObligationInterestExpense
|
27915000 | usd |
| CY2023 | adc |
Increase Decrease To Royalty Obligation Cumulative Catch Up Adjustment Other Net
IncreaseDecreaseToRoyaltyObligationCumulativeCatchUpAdjustmentOtherNet
|
-4972000 | usd |
| CY2023Q4 | adc |
Deferred Royalty Obligation
DeferredRoyaltyObligation
|
309613000 | usd |
| CY2024Q1 | adc |
Increase Decrease To Royalty Obligation Royalty Payments
IncreaseDecreaseToRoyaltyObligationRoyaltyPayments
|
-1229000 | usd |
| CY2024Q1 | adc |
Increase Decrease To Royalty Obligation Interest Expense
IncreaseDecreaseToRoyaltyObligationInterestExpense
|
8093000 | usd |
| CY2024Q1 | adc |
Increase Decrease To Royalty Obligation Cumulative Catch Up Adjustment Other Net
IncreaseDecreaseToRoyaltyObligationCumulativeCatchUpAdjustmentOtherNet
|
-263000 | usd |
| CY2024Q1 | adc |
Deferred Royalty Obligation
DeferredRoyaltyObligation
|
316214000 | usd |
| CY2024Q1 | adc |
Capital And Interest Guarantee Defined Benefit Plan
CapitalAndInterestGuaranteeDefinedBenefitPlan
|
1 | |
| CY2024Q1 | us-gaap |
Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
|
164000 | usd |
| CY2023Q1 | us-gaap |
Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
|
82000 | usd |
| CY2024Q1 | us-gaap |
Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
|
-41000 | usd |
| CY2023Q1 | us-gaap |
Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
|
-39000 | usd |
| CY2024Q1 | us-gaap |
Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
|
102000 | usd |
| CY2023Q1 | us-gaap |
Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
|
125000 | usd |
| CY2024Q1 | us-gaap |
Revenues
Revenues
|
18053000 | usd |
| CY2023Q1 | us-gaap |
Revenues
Revenues
|
18992000 | usd |
| CY2024Q1 | us-gaap |
Revenues
Revenues
|
18053000 | usd |
| CY2023Q1 | us-gaap |
Revenues
Revenues
|
18992000 | usd |
| CY2022Q4 | adc |
Gross To Net Sales Adjustment
GrossToNetSalesAdjustment
|
3746000 | usd |
| CY2023Q1 | adc |
Gross To Net Sales Adjustment Provision
GrossToNetSalesAdjustmentProvision
|
5616000 | usd |
| CY2023Q1 | adc |
Gross To Net Sales Adjustment Prior Period Adjustment
GrossToNetSalesAdjustmentPriorPeriodAdjustment
|
-648000 | usd |
| CY2023Q1 | adc |
Gross To Net Sales Adjustment Credits And Payments
GrossToNetSalesAdjustmentCreditsAndPayments
|
-4352000 | usd |
| CY2023Q1 | adc |
Gross To Net Sales Adjustment
GrossToNetSalesAdjustment
|
4362000 | usd |
| CY2023Q4 | adc |
Gross To Net Sales Adjustment
GrossToNetSalesAdjustment
|
11337000 | usd |
| CY2024Q1 | adc |
Gross To Net Sales Adjustment Provision
GrossToNetSalesAdjustmentProvision
|
6504000 | usd |
| CY2024Q1 | adc |
Gross To Net Sales Adjustment Prior Period Adjustment
GrossToNetSalesAdjustmentPriorPeriodAdjustment
|
-273000 | usd |
| CY2024Q1 | adc |
Gross To Net Sales Adjustment Credits And Payments
GrossToNetSalesAdjustmentCreditsAndPayments
|
-4407000 | usd |
| CY2024Q1 | adc |
Gross To Net Sales Adjustment
GrossToNetSalesAdjustment
|
13161000 | usd |
| CY2024Q1 | adc |
Trade And Other Current Receivables Sales Adjustment
TradeAndOtherCurrentReceivablesSalesAdjustment
|
2310000 | usd |
| CY2023Q4 | adc |
Trade And Other Current Receivables Sales Adjustment
TradeAndOtherCurrentReceivablesSalesAdjustment
|
2403000 | usd |
| CY2024Q1 | adc |
Current And Accrued Expenses And Other Current Liabilities Sales Adjustment
CurrentAndAccruedExpensesAndOtherCurrentLiabilitiesSalesAdjustment
|
10851000 | usd |
| CY2023Q4 | adc |
Current And Accrued Expenses And Other Current Liabilities Sales Adjustment
CurrentAndAccruedExpensesAndOtherCurrentLiabilitiesSalesAdjustment
|
8934000 | usd |
| CY2024Q1 | adc |
Gross To Net Sales Adjustment
GrossToNetSalesAdjustment
|
13161000 | usd |
| CY2023Q4 | adc |
Gross To Net Sales Adjustment
GrossToNetSalesAdjustment
|
11337000 | usd |
| CY2024Q1 | us-gaap |
Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
|
2900000 | usd |
| CY2023Q1 | us-gaap |
Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
|
2200000 | usd |
| CY2024Q1 | adc |
Deferred Royalty Obligation Interest Expense
DeferredRoyaltyObligationInterestExpense
|
8093000 | usd |
| CY2024Q1 | us-gaap |
Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
|
-41000 | usd |
| CY2023Q1 | us-gaap |
Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
|
-39000 | usd |
| CY2024Q1 | us-gaap |
Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
|
102000 | usd |
| CY2023Q1 | us-gaap |
Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
|
125000 | usd |
| CY2024Q1 | us-gaap |
Revenues
Revenues
|
18053000 | usd |
| CY2023Q1 | us-gaap |
Revenues
Revenues
|
18992000 | usd |
| CY2024Q1 | us-gaap |
Revenues
Revenues
|
18053000 | usd |
| CY2023Q1 | us-gaap |
Revenues
Revenues
|
18992000 | usd |
| CY2022Q4 | adc |
Gross To Net Sales Adjustment
GrossToNetSalesAdjustment
|
3746000 | usd |
| CY2023Q1 | adc |
Gross To Net Sales Adjustment Provision
GrossToNetSalesAdjustmentProvision
|
5616000 | usd |
| CY2023Q1 | adc |
Gross To Net Sales Adjustment Prior Period Adjustment
GrossToNetSalesAdjustmentPriorPeriodAdjustment
|
-648000 | usd |
| CY2023Q1 | adc |
Gross To Net Sales Adjustment Credits And Payments
GrossToNetSalesAdjustmentCreditsAndPayments
|
-4352000 | usd |
| CY2023Q1 | adc |
Gross To Net Sales Adjustment
GrossToNetSalesAdjustment
|
4362000 | usd |
| CY2023Q4 | adc |
Gross To Net Sales Adjustment
GrossToNetSalesAdjustment
|
11337000 | usd |
| CY2024Q1 | adc |
Gross To Net Sales Adjustment Provision
GrossToNetSalesAdjustmentProvision
|
6504000 | usd |
| CY2024Q1 | adc |
Gross To Net Sales Adjustment Prior Period Adjustment
GrossToNetSalesAdjustmentPriorPeriodAdjustment
|
-273000 | usd |
| CY2024Q1 | adc |
Gross To Net Sales Adjustment Credits And Payments
GrossToNetSalesAdjustmentCreditsAndPayments
|
-4407000 | usd |
| CY2024Q1 | adc |
Gross To Net Sales Adjustment
GrossToNetSalesAdjustment
|
13161000 | usd |
| CY2024Q1 | adc |
Trade And Other Current Receivables Sales Adjustment
TradeAndOtherCurrentReceivablesSalesAdjustment
|
2310000 | usd |
| CY2023Q4 | adc |
Trade And Other Current Receivables Sales Adjustment
TradeAndOtherCurrentReceivablesSalesAdjustment
|
2403000 | usd |
| CY2024Q1 | adc |
Current And Accrued Expenses And Other Current Liabilities Sales Adjustment
CurrentAndAccruedExpensesAndOtherCurrentLiabilitiesSalesAdjustment
|
10851000 | usd |
| CY2023Q4 | adc |
Current And Accrued Expenses And Other Current Liabilities Sales Adjustment
CurrentAndAccruedExpensesAndOtherCurrentLiabilitiesSalesAdjustment
|
8934000 | usd |
| CY2024Q1 | adc |
Gross To Net Sales Adjustment
GrossToNetSalesAdjustment
|
13161000 | usd |
| CY2023Q4 | adc |
Gross To Net Sales Adjustment
GrossToNetSalesAdjustment
|
11337000 | usd |
| CY2024Q1 | us-gaap |
Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
|
2900000 | usd |
| CY2023Q1 | us-gaap |
Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
|
2200000 | usd |
| CY2024Q1 | adc |
Deferred Royalty Obligation Interest Expense
DeferredRoyaltyObligationInterestExpense
|
8093000 | usd |
| CY2023Q1 | adc |
Deferred Royalty Obligation Interest Expense
DeferredRoyaltyObligationInterestExpense
|
5746000 | usd |
| CY2024Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
11100000 | usd |
| CY2023Q1 | adc |
Deferred Royalty Obligation Interest Expense
DeferredRoyaltyObligationInterestExpense
|
5746000 | usd |
| CY2024Q1 | us-gaap |
Interest Expense Other
InterestExpenseOther
|
0 | usd |
| CY2023Q1 | us-gaap |
Interest Expense Other
InterestExpenseOther
|
5000 | usd |
| CY2024Q1 | us-gaap |
Interest Expense
InterestExpense
|
12496000 | usd |
| CY2023Q1 | us-gaap |
Interest Expense
InterestExpense
|
10291000 | usd |
| CY2024Q1 | adc |
Deferred Royalty Obligation Cumulative Catch Up Adjustment
DeferredRoyaltyObligationCumulativeCatchUpAdjustment
|
-263000 | usd |
| CY2023Q1 | adc |
Deferred Royalty Obligation Cumulative Catch Up Adjustment
DeferredRoyaltyObligationCumulativeCatchUpAdjustment
|
-129000 | usd |
| CY2024Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-37000 | usd |
| CY2023Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-52000 | usd |
| CY2024Q1 | adc |
Research And Development Tax Credit
ResearchAndDevelopmentTaxCredit
|
-247000 | usd |
| CY2023Q1 | adc |
Research And Development Tax Credit
ResearchAndDevelopmentTaxCredit
|
-140000 | usd |
| CY2024Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-2595000 | usd |
| CY2023Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
833000 | usd |
| CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
11.00 | |
| CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
10744406 | shares |
| CY2023 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P8Y1M20D | |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
3.41 | |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
154200 | shares |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
12.67 | |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
277331 | shares |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
15.01 | |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
7886 | shares |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
5.00 | |
| CY2024Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
6384 | shares |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
11.21 | |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
10607005 | shares |
| CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P7Y3M29D | |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
|
5046977 | shares |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
10607005 | shares |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
|
18.64 | |
| CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P6Y | |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
2.68 | |
| CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
|
5560028 | shares |
| CY2024Q1 | us-gaap |
Interest Expense Other
InterestExpenseOther
|
0 | usd |
| CY2023Q1 | us-gaap |
Interest Expense Other
InterestExpenseOther
|
5000 | usd |
| CY2024Q1 | us-gaap |
Interest Expense
InterestExpense
|
12496000 | usd |
| CY2023Q1 | us-gaap |
Interest Expense
InterestExpense
|
10291000 | usd |
| CY2024Q1 | adc |
Deferred Royalty Obligation Cumulative Catch Up Adjustment
DeferredRoyaltyObligationCumulativeCatchUpAdjustment
|
-263000 | usd |
| CY2023Q1 | adc |
Deferred Royalty Obligation Cumulative Catch Up Adjustment
DeferredRoyaltyObligationCumulativeCatchUpAdjustment
|
-129000 | usd |
| CY2024Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-37000 | usd |
| CY2023Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-52000 | usd |
| CY2024Q1 | adc |
Research And Development Tax Credit
ResearchAndDevelopmentTaxCredit
|
-247000 | usd |
| CY2023Q1 | adc |
Research And Development Tax Credit
ResearchAndDevelopmentTaxCredit
|
-140000 | usd |
| CY2024Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-2595000 | usd |
| CY2023Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
833000 | usd |
| CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
10744406 | shares |
| CY2023 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P8Y1M20D | |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
3.41 | |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
154200 | shares |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
12.67 | |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
277331 | shares |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
15.01 | |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
7886 | shares |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
5.00 | |
| CY2024Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
6384 | shares |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
11.21 | |
| CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P7Y3M29D | |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
|
5046977 | shares |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
10607005 | shares |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
|
18.64 | |
| CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P6Y | |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
2.68 | |
| CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
|
5560028 | shares |
| CY2024Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
11100000 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-46606000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-59374000 | usd |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
82552322 | shares |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
82552322 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
80805770 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
80805770 | shares |
| CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.56 | |
| CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.56 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.73 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.73 | |
| CY2024Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
21553531 | shares |
| CY2023Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
20169013 | shares |
| CY2024Q1 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
| CY2024Q1 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
| CY2024Q1 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false | |
| CY2024Q1 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-46606000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-59374000 | usd |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
82552322 | shares |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
82552322 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
80805770 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
80805770 | shares |
| CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.56 | |
| CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.56 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.73 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.73 | |
| CY2024Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
21553531 | shares |
| CY2023Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
20169013 | shares |
| CY2024Q1 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
| CY2024Q1 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
| CY2024Q1 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false | |
| CY2024Q1 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false |
